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Abstract
Autoimmune diseases such as rheumatoid arthritis and coeliac disease are typical examples of complex genetic diseases
caused by a combination of genetic and non-genetic risk factors. Insight into the genetic risk factors (single nucleotide poly-
morphisms (SNPs)) has increased since genome-wide association studies (GWAS) became possible in 2007 and, for individual
diseases, SNPs can now explain some 15–50% of genetic risk. GWAS have also shown that some 50% of the genetic risk factors
for individual autoimmune diseases overlap between different diseases. Thus, shared risk factors may converge to pathways
that, when perturbed by genetic variation, predispose to autoimmunity in general. This raises the question of what deter-
mines disease specificity, and suggests that identical risk factors may have different effects in various autoimmune diseases.
Addressing this question requires translation of genetic risk factors to causal genes and then to molecular and cellular path-
ways. Since>90% of the genetic risk factors are found in the non-coding part of the genome (i.e. outside the exons of protein-
coding genes) and can have an impact on gene regulation, there is an urgent need to better understand the non-coding part
of the genome. Here, we will outline the methods being used to unravel the gene regulatory networks perturbed in autoim-
mune diseases and the importance of doing this in the relevant cell types. We will highlight findings in coeliac disease, which
manifests in the small intestine, to demonstrate how cell type and disease context can impact on the consequences of
genetic risk factors.
Context Specificity of Gene Regulation
Transcription regulation is a complex system which includes
enhancers and promoters, transcription factors and their bind-
ing sites, and regulatory RNAs such as long non-coding RNAs,
that all act in highly cell type-specific manners to achieve ap-
propriate levels of gene expression. To further our understand-
ing of the non-coding genome, there is a range of different
techniques needed to comprehensively investigate the regula-
tory elements, each with its own challenges and limitations
(Box 1). Many large consortia, such as ENCODE (1), Epigenome
Roadmap (2), Blueprint (3) and FANTOM (4), have used these
techniques to systematically document the individual elements
including enhancers and non-coding RNAs, in more than 100
different cell types and even under different conditions. These
initiatives have moved the field of transcription regulation for-
ward considerably, but have also clearly shown that especially
enhancers and non-coding RNAs are extremely cell type- and
condition-specific (2,5,6) (Fig. 1). For example, AP001057.1 is a
long non-coding RNA (lncRNA) gene that is exclusively ex-
pressed in monocytes and upregulated upon induction with mi-
crobial agents. This lncRNA is located in a locus associated with
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coeliac disease and Crohn’s disease (5). Naturally, since the
non-coding genome is cell type- and condition-specific manner,
so too is the disruption of the non-coding genome by genetic
variants associated with diseases.
An important step in understanding the role of the non-
coding genome in disease is to link disease-specific risk single
nucleotide polymorphism (SNPs) to their target genes. This can
be done in two ways: firstly, by identifying causal SNPs in non-
coding regions and linking their function to causal genes, and
secondly, by correlating gene expression with genotype. In
many ways, the first approach is more informative, as the mo-
lecular mechanism for the causative effect on gene expression
will be identified. However, identifying the true causal SNPs pre-
disposing to disease is highly complicated because of the pres-
ence of linkage disequilibrium (LD) (7), the phenomenon that
multiple genetic variants close to each other are co-inherited to-
gether and therefore cannot be distinguished. But even within a
long stretch of correlated SNPs, their evidence for being causal
increases when they overlap enhancers (8–10), when they dis-
rupt predicted motifs including transcription factor binding
sites (11–13), and/or when they overlap evolutionary conserved
regions (14).
Alternatively, a powerful tool used in the second approach is
cis-eQTL (expression quantitative trait loci) analysis, i.e. identi-
fying genes whose level of expression is correlated with a close-
by SNP. One example that shows the power of eQTL analysis is
the obesity-associated SNP, rs1421085, that is located in one of
the introns of the FTO gene. As there was no SNP that disrupted
a protein-coding sequence, FTO was considered to be an excel-
lent positional candidate gene. Many follow-up and functional
studies have been conducted on FTO and led to more than 1,000
scientific articles, until Claussnitzer et al. discovered that
rs1421085 affects the expression of IRX3, a transcription factor
important for neuronal development, in brain tissue. Functional
follow-up of IRX3 offers convincing evidence for this gene play-
ing a role in obesity (15).
Examples of both approaches and the insights they have
yielded on the role of genetics in autoimmune diseases are
described later in this review.
Genetic Variants Associated with Autoimmune
Disease Are Enriched in Regulatory Elements
Intersecting disease-associated SNPs with data on regulatory el-
ements can be used to pinpoint causal variants among a set of
SNPs in high LD. Autoimmune diseases have been prime exam-
ples for conducting such studies, as there are ample data on
different immune cell types (1–4). Performing such an analysis
on SNPs associated with coeliac disease showed significant en-
richment in B-cell-specific enhancers (16). These results have
not only helped to define potentially causal SNPs, but also imply
an important role for B-cells in a disease that is traditionally re-
garded as a T-cell disorder. Trynka et al. (17) showed that active
non-coding regions in CD4þ regulatory T-cells overlapped with
31 SNPs associated with rheumatoid arthritis, implying a promi-
nent role for these cells in its aetiology. The Epigenome
Roadmap consortium, which has annotated regulatory ele-
ments based on epigenetic marks in 111 different primary tis-
sues and cell types, both under resting and stimulated
conditions, has allowed a systematic enrichment analysis to be
performed (8). Indeed, all autoimmune diseases display enrich-
ment of SNPs in non-coding regions of different subsets of im-
mune cells. Moreover, SNPs associated with type 1 diabetes
overlap regulatory elements in pancreatic islets, while SNPs for
Crohn’s disease and ulcerative colitis are enriched in regulatory
elements in the colonic mucosa (8), indicating that cell types
other than immune cells are also important in autoimmune
diseases.
While enrichment analysis helps to prioritize potentially
causal SNPs, it does not prove their causality. The most likely
mechanism by which causal SNPs act is by disruption of tran-
scription factor binding sites (11,13,15,18–20). For example, SNPs
associated with coeliac disease and rheumatoid arthritis disrupt
binding sites of T-BET (19), IRF1 (20), AP-1 (8) and of transcription
factors that interact with IRF9 (11). Surprisingly, only 1–20%, de-
pending on the transcription factor, of the SNPs that disrupt a
transcription factor binding site in a regulatory region also lead to
changed activity of the regulatory element, either in a constitu-
tive or cell-type-specific manner (15); this is based on measuring
allelic imbalance between the two different haplotypes (Fig. 2).
Large-scale massive parallel reporter assays of eQTL-SNPs have
identified SNPs that affect the activity of regulatory elements in
lymphoblastoid cell lines (21), including rs9283753, an SNP associ-
ated with ankylosing spondylitis that overlaps a distal enhancer
of the prostaglandin E receptor 4 gene (PTGER4). Still, less than 3%
of all the SNPs tested changed regulatory activity (21). Overall,
causal SNPs have not been identified for the vast majority of ge-
netic loci associated with autoimmune diseases, which may be
due to the fact that most epigenetic annotations are derived from
cells under resting conditions whereas autoimmune disease
SNPs that are prioritized to be causal seem to be enriched, mainly
in stimulated cell types (8).
Finally, identification of causal SNPs is not enough to infer
downstream effects of the SNPs active in disease. Therefore,











Figure 1. LncRNAs and enhancers are more cell-type-specific than protein-coding gene expression. Schematic representation of the correlation between the activities
of protein-coding genes (purple), non-coding RNAs (blue) and enhancers (green).
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linked to the affected genes. The most elegant way to do so is by
mapping the looping interactions between non-coding regions
and the genes they regulate by using chromatin capture tech-
niques such as 4 C, promoter capture HiC and ChIA-PET (Box 1)
(10,11,15,22,23). This has prioritized multiple genes over long
distances from the GWAS SNPs, including genes that are out-
side the typical cis-window of 500 kb-1 Mb (Megabase) used in
cis-eQTL analysis. For example, FOXO1 has an interaction with a
non-coding region that overlaps a rheumatoid arthritis and ju-
venile idiopathic arthritis SNP over 1 Mb away (22). However, 3D
interaction data are not commonly generated, making it diffi-
cult to detect the loop between causal SNPs and genes. The
Blueprint consortium (3) has started to close this gap and ana-
lysed promoter capture HiC for 17 primary immune cell types
(24), thereby prioritizing 421 genes for autoimmune diseases
based on GWAS summary statistics and 3D interaction data.
Thus, with increasing understanding of how the non-coding
genome regulates gene expression in relevant cell types, it will
be feasible to fine map and understand the mechanisms of
causal SNPs in autoimmune disease.
SNPs Have Variable Effects Based on Cell Type
and Context
Fine mapping and functionally linking causal SNPs to affected
genes reveals a great deal about the molecular mechanisms by
which SNPs affect autoimmune diseases, but does not allow for
high-throughput detection of causal genes. So eQTL analysis is
more commonly used as a direct way of detecting the effects of
genetic variation on gene expression (Fig. 2).
Most large eQTL studies to date have used peripheral blood
expression data (10,16,25–30) and approximately 42% of SNPs
associated with autoimmune diseases can be linked to a nearby
gene by using gene expression data from peripheral blood (10).
These eQTL studies showed that disease SNPs can also affect
the expression of long non-coding RNAs (10,31), suggesting that
risk SNPs may interfere with transcription regulation through
regulatory RNAs. Although peripheral blood is likely to be ap-
propriate for many of the SNPs associated with autoimmunity,
risk SNPs for other diseases may fail to show an effect in blood
and need to be investigated in other cell types. Moreover, how
eQTL genes exert an effect in disease aetiology is difficult to in-
terpret without knowing the cell type in which the gene is de-
regulated due to genetic variants. Several strategies have been
applied to circumvent these issues.
First, statistical methods can be applied to reassign eQTL sig-
nals to specific cell types or conditions in heterogeneous sam-
ples including peripheral blood (29,32,33). The largest eQTL
study to date classified 12% of over 23,000 eQTLs as cell-type-
specific (29). But a limitation is that these methods may not be
able to capture a specific context including exposure to an anti-
gen, or a rare cell type.
Alternatively, eQTL analysis can be performed in specific tis-
sues, for example as done by the GTeX consortium and others
(34–36) or by sorting whole blood into its major cell types
(12,18,20,37–43). These approaches are much more expensive to
perform and these eQTL studies are thus done on smaller co-
horts and have reduced power. Nonetheless, many unique
eQTLs have been identified by studies on specific cell types (Figs
2 and 3). For example, a neutrophil-specific change in the gene
expression of protein-arginine deiminase type IV (PADI-4) due
to the rheumatoid arthritis-associated SNP rs2240335 only over-
laps with H3K27Ac marks in neutrophils, but not in monocytes
and a further 450 out of 3281 neutrophil cis-eQTLs were not ob-
served in non-neutrophil myeloid or lymphoid cell lineages (18).
Comparison of the highly related CD4þ and CD8þ T cells also
identified interleukin 27 as a protective eQTL gene for type 1 di-
abetes exclusively in CD4þ T cells (40).
Not only the specific cell type may be important in identify-
ing eQTLs, the context in which the cells operate is also relevant
for autoimmune diseases, since these require interaction with
auto-antigens for the disease to manifest (Fig. 3). Multiple
Figure 2. eQTLs can be cell-type-specific. Schematic representation of a genetic risk locus with variable effects on gene expression in cis, depending on cell type. From
top to bottom: the cell type, the gene annotation track with SNPs (in red triangles), a cell-type-specific DHS-seq track displaying open chromatin regions (in black) and
causal mutations and allele-specific open chromatin (in green and red); and the eQTL effects of causal mutations in each cell type. Left: gene X displays an eQTL effect
in CD4þ T cells caused by a G-to-T mutation in an active enhancer. Right: in neutrophils, gene X is not differentially regulated by the G-to-T mutation, but gene Y is
affected by an A-to-G mutation in the same locus.
R187Human Molecular Genetics, 2017, Vol. 26, No. R2 |
Downloaded from https://academic.oup.com/hmg/article-abstract/26/R2/R185/3932274
by Rijksuniversiteit Groningen user
on 21 December 2017
studies have identified eQTLs that are not detected under rest-
ing conditions, but which appear strongly after stimulation
(20,38,41,44). This also depends on the stimulant and the time
of stimulation, as Fairfax et al. have shown by stimulating
monocytes with LPS for 2 hours and with LPS or interferon c
(IFNc) for 24 hours (38). Some genes even show opposing eQTL
effects between stimulated and resting conditions (for example,
HIP1, STEAP4 and CEACAM3), or between different stimulants
(CEACAM3), demonstrating how complex the contribution of
SNPs to disease can be. So detecting cell-type- and condition-
specific eQTLs increases detection of eQTLs in general and of-




To demonstrate how context- and cell-type-specific eQTL analy-
sis can contribute to understanding autoimmune diseases, we
have taken coeliac disease as an example. We extracted all
the eQTL genes identified in a cell-type-specific context
(12,18,20,35–38,40,42), but not in peripheral blood (10,16,28,45–
47) (Fig. 3). Many of these genes have functions that are highly
relevant for coeliac disease. For example, REL, encoding an
Nuclear factor jB (NF-jB) subunit, is an eQTL in CD4þ T cells,
the cell type that recognizes and responds to the gluten pep-
tides that trigger coeliac disease and set in motion a chain of
events leading to inflammation and an autoimmune response
in the small intestines (9,48). A major signalling pathway that
regulates this response is NF-jB pathway (49), so any changes in
levels of NF-jB subunits in CD4þ T cells can have profound ef-
fects on the severity of the response to gluten peptides. Another
example is protein tyrosine phosphatase non-receptor type 2
(PTPN2), which shows an eQTL effect in stimulated monocytes
only (Fig. 3). PTPN2 encodes a phosphatase involved in the
monocyte response to IFNc in inflammatory bowel disease (IBD)
and rheumatoid arthritis (50–52), thus a similar role in coeliac
disease is possible since IFNc is a major coeliac disease-
associated cytokine (9,48,53). To conclude, many genetic vari-
ants may have effects in a cell-type-specific manner, and detec-
tion of these effects can provide direct insights into disease
mechanisms.
While these eQTLs have allowed us to prioritize the genes
and pathways that are pivotal to disease aetiology, it is still
unclear whether these genes are truly causal. Statistical tools
that make use of the relationship between GWAS summary sta-
tistics and eQTL-SNP pairs to distinguish which eQTLs best ex-
plain the genetic effect on disease, have only been moderately
successful (54–57) and the lack of cell–type- and condition-
specific eQTL data were given as one of the possible reasons for
this (56).
Therefore, it is critical to understand the conditions and cir-
cumstances in which autoimmune diseases occur. However,
unlike coeliac disease, these circumstances are unknown for
most autoimmune diseases and for coeliac disease many ques-
tions remain as well. Even though gluten peptides have been
identified as the direct trigger of coeliac disease, the full context
in which mucosal inflammation takes place is highly complex.
Many cytokines including IFNc, IL15 and IL21 play an important
role (9,48,53) and recently, Bouziat et al have shown that specific
strains of Reovirus can invoke tolerance to gluten in mice, sug-
gesting that virus infections can trigger coeliac disease (58).
Moreover, commensal gut microbes have also been implicated
in coeliac disease (59). Consequently, even for coeliac disease, it
is nearly impossible to emulate the context in which genetic
variants exert an effect on gene expression.
However, different stimuli have different effects on gene ex-
pression and the role of genetic variation might be specific to
Figure 3. Cell-type- and context-specific eQTLs for coeliac disease. All lead SNPs from coeliac disease risk loci and proxy-SNPs in LD (r2>0.8) were compared to periph-
eral blood eQTL studies and cell- and context-specific eQTL studies. eQTLs unique for these studies are shown along with the cell type and context in which they were
identified.
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each separate stimulus. Comparative expression analysis of dif-
ferent pathogens has shown pathogen-specific gene expression
changes in immune cells (20,60) and production of variable lev-
els of cytokines (61–63). Moreover, cytokine production is influ-
enced by genetic variants in a pathogen-specific manner (61,
63). So to truly capture the effects of genetic variation involved
in autoimmune diseases, it may be necessary to analyse patient
material as all the patient’s conditions will be conducive to the
pathology.
Concluding Remarks
Since the association of genetic loci with autoimmune diseases,
many eQTL and fine-mapping studies have been performed and
made great strides in identifying putative causal genes and
pathways affected by genetic variation associated with disease.
However, the consequences of genetic variants may depend
greatly on the cell type and conditions in which they are mea-
sured. As disease-specific cell types and conditions are often
poorly defined in autoimmune disease, detection of eQTLs in
patient-derived material may be the most straightforward way
(35,36). Unfortunately, the availability of material from suffi-
cient numbers of patients and the amount of material itself are
often limiting factors, making analysis of these samples diffi-
cult. However, sequencing techniques have improved over the
years, making single-cell transcriptome and single-cell epige-
nome sequencing possible (Box 1). Moreover, statistical decon-
volution of eQTL effects in solid tissues into single cell types is
becoming increasingly sensitive (33,64). Thus, with the use of
statistical approaches and sophisticated techniques that re-
quire minimum amounts of input material, we can begin to dis-
cover the cell- and context-specific role of genetic variation in
autoimmune disease.
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Table 1. Overview of methods that can be applied to characterize the non-coding, regulatory genome
Characteristic Method Lower limit for input material
Open chromatin DHS-seq 5 million cells (65)
ATAC-seq 50,000 to a single cell (71,72)
Epigenetic marks ChIP-seq 1 million to a single cell (66,67,73)
Transcription activity CAGE/nanoCAGE 5 million to 1,000 cells (74, 75)
GRO/PRO-seq 5 million cells (76,77)
NET-seq 10 million cells (78)
Looping interaction 4C/5C 5–10 million cells (79,80)
ChIA-PET 100 million cells (81)
HiC 2–5 million to a single cell (82,83)
ATAC-seq, Assay for transposase-accessible chromatin sequencing; CAGE, Cap analysis gene expression; ChIA-PET, Chromatin interaction analysis by paired-end se-
quencing; ChIP-seq, Chromatin immunoprecipitation sequencing; DHS-seq, DNase I hypersensitivity sequencing; GRO-seq, Global run-on sequencing; NET-seq, Native
elongating transcript sequencing; PRO-seq, Precision run-on sequencing
Box 1. Characterizing the non-coding genome
Functional elements in the non-coding genome have a variety of characteristics that determine their potential role, target and
activity in individual cell types. For example, enhancers and promoters are generally devoid of nucleosomes so that transcription
factors can bind more freely (65). This open chromatin is also characterized by epigenetic marks associated with active chroma-
tin including H3K4 mono- and tri-methylation and H3K27 acetylation (66–68). Moreover, active promoters and enhancers are typ-
ically transcriptionally active, often producing non-coding RNA that can have regulatory functions (68,69). Finally, in order for
enhancers to regulate genes, a physical interaction or looping between the enhancer and the target gene is necessary (24,70). All
these characteristics can be measured in vivo with the methods described in Table 1.
Many of these methods require large numbers of cells, which makes them difficult to use for some of the rarer and more difficult
to obtain cell types that are specific for certain diseases. However, recent advances in next-generation library preparation and se-
quencing techniques has led to needing less starting material for many of the assays that measure activity in the non-coding ge-
nome, making it possible to study rare and valuable cells that are disease-specific in detail.
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